Progesterone is a hormone that occurs naturally in females, and is essential for endometrial receptivity, embryo implantation, and the successful establishment of pregnancy. A low progesterone concentration or an insufficient response to progesterone can cause infertility and pregnancy loss . Progesterone is used in various contraceptive preparations to prevent ovulation and fertilization , as well as in other formulations to promote and support pregnancy. Please see Medroxyprogesterone acetate, Megestrol acetate, Dydrogesterone and Hydroxyprogesterone entries for information on various other forms of progesterone.
Pharmaceutical progesterone is made from a plant source as a starting material and is chemically identical to progesterone of human ovarian origin . Progesterone is available in gelatinized capsule form, vaginal gel form, tablet form, vaginal insert form, and injection form, all used for various purposes .
Gelatinized capsules
The gelatinized capsules are indicated for use in the prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea .
Vaginal gel
Progesterone gel (8%) is indicated as progesterone supplementation or replacement as part of an Assisted Reproductive Technology (“ART”) treatment for infertile women with progesterone deficiency. The lower concentration progesterone gel (4%) is used in the treatment of secondary amenorrhea, with the use of the 8% concentration if there is no therapeutic response to the 4% gel .
Vaginal insert
This form is indicated to support embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an Assisted Reproductive Technology (ART) treatment program for infertile women .
Injection (intramuscular)
This drug is indicated in amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer .
Tablets, contraceptive
The tablet form of progesterone in contraceptive formulations is indicated for the prevention of pregnancy .
Centre of Reproductive Medicine CRG, Jette, Brussels, Belgium
The Woman's Hospital of Texas Clinical Research Center, Houston, Texas, United States
Precision Clinical Trials/Arizona Wellness Center for Women, Phoenix, Arizona, United States
Precision Trials/New Horizons Women's Care, Chandler, Arizona, United States
Obstetric and Gynaecology Department, National University of Malaysia Medical Centre, Cheras, Kuala Lumpur, Malaysia
Yale School of Medicine Dpt of Psychiatry, New Haven, Connecticut, United States
Penn Center for Women's Behavioral Wellness, Philadelphia, Pennsylvania, United States
Accelovance, Melbourne, Florida, United States
Clinical Research of Philadelphia, Philadelphia, Pennsylvania, United States
Radiant Research (Chicago), Chicago, Illinois, United States
UZ Brussel, Brussels, Belgium
Indiana Clinical Research Center, Indianapolis, Indiana, United States
Purdue University, Indianapolis, Indiana, United States
Centre for Reproductive Medicine, Brussels, Belgium
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.